A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/29/2011	CA2803164A1 Amide-based insulin prodrugs
12/29/2011	CA2803027A1 Treatment of proliferative diseases
12/29/2011	CA2803003A1 Methods and compositions for cns delivery of arylsulfatase a
12/29/2011	CA2802932A1 Long-term storage of non-glycosylated recombinant human g-csf
12/29/2011	CA2802897A1 Glucagon analogues
12/29/2011	CA2802889A1 Glucagon analogues
12/29/2011	CA2802209A1 Sustained-release formulation
12/29/2011	CA2800261A1 Treatment of vascular complications of diabetes
12/29/2011	CA2800206A1 Methods and pharmaceutical compositions for the treatment of respiratory tract infections
12/29/2011	CA2796894A1 Amide based glucagon superfamily peptide prodrugs
12/29/2011	CA2796879A1 Dipeptide linked medicinal agents
12/29/2011	CA2745102A1 Pharmaceutical composition and method of use to improve organ function
12/28/2011	EP2400021A2 ErbB3 based methods and compositions for treating neoplasms
12/28/2011	EP2399994A1 Thrombin mutant
12/28/2011	EP2399939A2 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof
12/28/2011	EP2399932A1 Compositions and methods for modulating immune responses
12/28/2011	EP2399931A1 New octapeptide compounds and their therapeutic use
12/28/2011	EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation
12/28/2011	EP2399927A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
12/28/2011	EP2399893A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
12/28/2011	EP2399601A1 Botulinum toxin therapy
12/28/2011	EP2399600A1 Treatment of inflammatory bowel diseases with mammal beta defensins
12/28/2011	EP2399599A2 Mucin hypersecretion inhibitors and methods of use
12/28/2011	EP2399598A1 Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer
12/28/2011	EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/28/2011	EP2399587A1 Liposome treatment of viral infections
12/28/2011	EP2399586A1 Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
12/28/2011	EP2399572A1 Long-term storage of non-glycosylated recombinant human G-CSF
12/28/2011	EP2398904A1 Means for purifying a coagulation protein, and methods for implementing same
12/28/2011	EP2398824A1 Means and methods for manufacturing highly pure neurotoxin
12/28/2011	EP2398822A1 Modification of factor viii
12/28/2011	EP2398820A2 Cancer-targeting peptides and uses thereof in cancer therapy
12/28/2011	EP2398495A1 Modified non-cytotoxic proteases
12/28/2011	EP2398494A2 Proproteins and methods of use thereof
12/28/2011	EP2398493A1 Use of g-csf for the extension of the therapeutic time-window of thrombolytic stroke therapy
12/28/2011	EP2398492A1 Cytotoxic conjugates having neuropeptide y receptor binding compound
12/28/2011	EP2398491A1 Sphingosine 1-phosphate antagonism
12/28/2011	EP2398490A2 Modifications of cupredoxin derived peptides and methods of use thereof
12/28/2011	EP2398489A2 Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms
12/28/2011	EP2398488A1 Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
12/28/2011	EP2398486A1 Compositions and methods to prevent and/or treat cancer with pa -card
12/28/2011	EP2398485A1 Analogues of neuropeptide y having at least one synthetic amino acid substitution
12/28/2011	EP2398484A1 Inhibition of multiple cell activation pathways
12/28/2011	EP2398483A1 Oxyntomodulin analogs
12/28/2011	EP2398479A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2170941B1 Preprocalcitonin antigen t epitopes
12/28/2011	EP2132224B1 Cyclic receptor-associated protein (rap) peptides
12/28/2011	EP1871391B1 Endogenous retrovirus and proteins encoded by env as a target for cancer treatment
12/28/2011	EP1796707B1 Peptides that selectively home to heart vasculature and related conjugates and methods
12/28/2011	EP1704164B1 Interleukin-11 fusion proteins
12/28/2011	EP1599221B1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin
12/28/2011	EP1596828B1 Lipophilic drug delivery vehicle and methods of use thereof
12/28/2011	EP1572080B1 Fgf variants and methods for use thereof
12/28/2011	EP1556027B1 Modified amino acid 5-cnac for the inhibition of platelet aggregation
12/28/2011	EP1536688B1 Mammalian megakaryocyte progenitor cell
12/28/2011	EP1411918B1 Methods to mobilize progenitor/stem cells
12/28/2011	EP1316315B1 Serum thymic factor for use in the treatment of oxidative stress in allergy
12/28/2011	EP1234033B1 Methods for targeting cells that express fibroblast growth factor receptor-3 or-2
12/28/2011	CN1960699B 角蛋白结合多肽 Keratin-binding polypeptide
12/28/2011	CN1774259B 治疗系统性红斑狼疮的肽的胃肠道外制剂 Parenteral preparations for treatment of systemic lupus erythematosus peptides
12/28/2011	CN1671737B 以羊毛硫抗生素途径输出并修饰(多)肽 In lantibiotic export pathway and modified (poly) peptide
12/28/2011	CN102300987A 膜型-1基质金属蛋白抑制剂及其用途 -1 Membrane type matrix metalloproteinase inhibitors and their use
12/28/2011	CN102300582A 用于治疗阿尔茨海默病的化合物和方法 Compounds and methods for the treatment of Alzheimer's disease
12/28/2011	CN102300581A 用于治疗因神经原纤维缠结和β淀粉状蛋白的积聚引起的进行性认知功能障碍的瘦蛋白组合物和方法 Treatment of progressive cognitive dysfunction due to the accumulation of neurofibrillary tangles and amyloid β caused leptin compositions and methods for
12/28/2011	CN102300580A 二肽连接的药剂 Pharmacy dipeptide connected
12/28/2011	CN102300542A 一种用于定量释放单剂量的用于口服的t3和t4甲状腺激素溶液的药用容器 A method for the quantitative release of a single dose of t3 and t4 thyroid hormone solution for oral pharmaceutical container
12/28/2011	CN102295695A 重组人促卵泡激素及其制备 Recombinant human follicle-stimulating hormone and its preparation
12/28/2011	CN102295694A 一种抗菌多肽及其制备方法和应用 An antimicrobial peptide and its preparation method and application
12/28/2011	CN102295683A 抗单纯疱疹病毒多肽及其应用 Anti-herpes simplex virus peptides and its application
12/28/2011	CN102295682A Hla-a1101限制的wt1肽及含有其的药物组合物 Hla-a 1101 restricted wt1 peptide and a pharmaceutical composition comprising the same
12/28/2011	CN102294022A Sod制剂及其制取方法 Sod preparation and its preparation method
12/28/2011	CN102294021A 一种可降低血糖的药物制剂 One kind of pharmaceutical preparations can reduce blood sugar
12/28/2011	CN102294020A 空间构象改变的干扰素及其应用 Spatial conformational changes interferon and its Application
12/28/2011	CN102294019A 金环蛇抗菌肽cathelicidin－BF的应用 Krait antimicrobial peptide cathelicidin-BF application
12/28/2011	CN102294018A 一种阿霉素与膜联蛋白v偶联物及其制备方法和应用 Doxorubicin and annexin v conjugates and its preparation method and application
12/28/2011	CN102294017A 畜禽益生菌口服液及其制备方法 Livestock and oral probiotic preparation
12/28/2011	CN102294016A 治疗血管相关疾病的包含肽的药物组合物 Treating vascular-related diseases of a pharmaceutical composition comprising a peptide
12/28/2011	CN102294015A 一种用于肿瘤靶向治疗的药物组合物及其制备方法 A pharmaceutical composition for the treatment of tumor targeting and preparation method
12/28/2011	CN102294014A 一种促肝细胞生长素，其制剂和用途 A pro-hepatocyte growth factor, their preparation and use
12/28/2011	CN102294013A 一种促肝细胞生长素，其制剂及应用 A pro-hepatocyte growth factor, and its preparation and application
12/28/2011	CN102293756A 一种尿促性素冻干粉针剂及其制备方法 A gonadotropin freeze-dried powder and a preparation method of urine
12/28/2011	CN102293748A 一种口服聚乙二醇化胰岛素pH敏感纳米粒及其制备方法 An oral PEGylated insulin-pH-sensitive nanoparticles and a preparation method
12/28/2011	CN101862457B 一种可降解高分子载体药物及其制备方法和应用 One kind of biodegradable polymer drug carrier and its preparation method and application
12/28/2011	CN101812436B 一种尖吻蝮蛇蛇毒类凝血酶及其制备方法和应用 One kind of Agkistrodon venom thrombin-like enzyme and its preparation method and application
12/28/2011	CN101693737B 一类具有抗氧化活性的角类多肽、其分离方法及用途 A class of horns peptides with antioxidant activity, and its separation method and uses
12/28/2011	CN101683323B 含有万古霉素的结肠靶向微丸及其制备方法 Colon pellets and its preparation containing vancomycin
12/28/2011	CN101602799B 一种鹰嘴豆中原生抗菌多肽的快速制备方法 Rapid method for preparing chickpeas natively antimicrobial peptides
12/28/2011	CN101597322B Tyr-Ile-Gly-Ser-Arg的17种类似物，其合成及在医学中的应用 Tyr-Ile-Gly-Ser-Arg 17 kinds of analog synthesis and its application in medicine
12/28/2011	CN101549149B 一种新的降钙素的水溶液鼻用喷雾制剂 A new aqueous nasal spray formulation of calcitonin
12/28/2011	CN101282736B 用于减轻肌肉炎症的乳清生长因子提取物的组合物 The composition for reducing muscle inflammation of whey growth factor extract
12/28/2011	CN101244262B 一种治疗细菌性感染的药物联合药剂 A bacterial infection of the combination drug therapy agent
12/28/2011	CN101244260B 一种治疗慢性乙型肝炎的联合用药物 A treatment for chronic hepatitis B combination with drugs
12/28/2011	CN101171021B 喷射液体、喷射方法、形成液滴的方法、液体喷射卡盒和喷射设备 The method of ejecting liquid ejecting method, the formation of droplets, and a liquid ejecting apparatus ejecting the cartridge
12/27/2011	US8084596 Regulated apoptosis
12/27/2011	US8084591 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders
12/27/2011	US8084580 Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them
12/27/2011	US8084579 Silver halide emulsion for improving photographic products such as photographic paper or cellulose films
12/27/2011	US8084578 Monoclonal antibody against human scavenger receptor SRCL-P1
12/27/2011	US8084574 Carbon nanotube binding peptides
12/27/2011	US8084573 Carbon nanotube binding peptides

1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 3163